Ignite Creation Date:
2025-12-24 @ 7:34 PM
Ignite Modification Date:
2026-05-06 @ 3:23 PM
Study NCT ID:
NCT01915303
Status:
TERMINATED
Last Update Posted:
2020-09-18
First Post:
2013-06-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cushings Disease | View |